Shares Magazine
53.50p+0.00 (+0.00%)25 Sep 2024, 14:07
Jump to:
Netscientific PLC Fundamentals
| Company Name | Netscientific PLC | Last Updated | 2024-09-25 |
|---|---|---|---|
| Industry | Biotechnology | Sector | Healthcare |
| Shares in Issue | 23.946 m | Market Cap | £12.81 m |
| PE Ratio | 0.00 | Dividend per Share | 0 |
| Dividend Yield | 0 | Dividend Cover | 0 |
| EPS | -£0.11 | EPS Growth (%) | 0 |
| PEG | 0 | DPS Growth (%) | 0 |
| Debt Ratio | 0.1127 | Debt Equity Ratio | 0.0988 |
| Asset Equity Ratio | 1.3124 | Cash Equity Ratio | 0.0203 |
| Quick Ratio | 0.2994 | Current Ratio | 0.38 |
| Price To Book Value | 0.7184 | ROCE | 0 |
Netscientific PLC Dividends
| Type | Ex-Date | Pay Date | Currency | Net Dividend | Year Total |
|---|
Netscientific PLC Company Financials
| Assets | 2023 | 2022 | 2021 |
|---|---|---|---|
| Tangible Assets | £394,000.00 | £564,000.00 | £294,000.00 |
| Intangible Assets | £2.76 m | £3.37 m | £3.04 m |
| Investments | £17.72 m | £22.74 m | £11.52 m |
| Total Fixed Assets | £21.11 m | £27.37 m | £16.32 m |
| Stocks | £52,000.00 | £76,000.00 | £67,000.00 |
| Debtors | £726,000.00 | £475,000.00 | £1.43 m |
| Cash & Equivalents | £347,000.00 | £580,000.00 | £2.35 m |
| Other Assets | £232,000.00 | £693,000.00 | £1.46 m |
| Total Assets | £22.46 m | £28.95 m | £20.69 m |
| Liabilities | 2023 | 2022 | 2021 |
|---|---|---|---|
| Creditors within 1 year | £3.58 m | £2.72 m | £1.62 m |
| Creditors after 1 year | £1.76 m | £987,000.00 | £563,000.00 |
| Other Liabilities | 0 | 0 | 0 |
| Total Liabilities | £5.35 m | £3.71 m | £2.18 m |
| Net assets | £17.11 m | £25.24 m | £18.51 m |
| Equity | 2023 | 2022 | 2021 |
|---|---|---|---|
| Called up share capital | £1.18 m | £1.17 m | £1.06 m |
| Share Premium | £74.22 m | £74.17 m | £72.79 m |
| Profit / Loss | -£2.90 m | -£3.71 m | -£2.92 m |
| Other Equity | £17.83 m | £25.84 m | £18.50 m |
| Preference & Minorities | -£720,000.00 | -£598,000.00 | £9,000.00 |
| Total Capital Employed | £17.11 m | £25.24 m | £18.51 m |
| Ratios | 2023 | 2022 | 2021 |
|---|---|---|---|
| Debt Ratio | £0.09 | £0.04 | £0.03 |
| Debt-to-Equity | £0.10 | £0.04 | £0.03 |
| Assets / Equity | 1.3124 | 1.3124 | 1.3124 |
| Cash / Equity | 0.0203 | 0.0203 | 0.0203 |
| EPS | -£0.17 | -£0.17 | -£0.13 |
| Cash Flow | 2023 | 2022 | 2021 |
|---|---|---|---|
| Cash from operating activities | -£3.14 m | -£2.56 m | -£3.48 m |
| Cashflow before financing | -£1.75 m | -£819,000.00 | £4.54 m |
| Increase in Cash | -£640,000.00 | -£1.90 m | £1.08 m |
| Income | 2023 | 2022 | 2021 |
|---|---|---|---|
| Turnover | £1.45 m | £1.00 m | £1.11 m |
| Cost of sales | £219,000.00 | £222,000.00 | £118,000.00 |
| Gross Profit | £1.23 m | £782,000.00 | £989,000.00 |
| Operating Profit | -£2.64 m | -£3.74 m | -£2.96 m |
| Pre-Tax profit | -£2.90 m | -£3.71 m | -£2.92 m |
Netscientific PLC Company Background
| Sector | Healthcare |
|---|---|
| Activities | NetScientific PLC is a transatlantic healthcare technology company. The group is focused on sourcing, funding, and commercializing technologies and companies that have the potential to treat chronic diseases and significantly improve the health and well-being of people. Its portfolio consists of WANDA Health, an analytics company that uses machine learning to derive a personalized risk score for Congestive Heart Failure patients, a provider of a non-invasive glucose monitoring wearable device, Vortex Biosciences which is engaged in circulating tumor cell identification, selection, and analysis for disease monitoring and personalized therapeutic prescribing, and Glycotest which provides non-invasive blood testsfor liver cancers and fibrosis-cirrhosis. |
| Latest Interim Date | 27 Sep 2024 |
| Latest Fiscal Year End Date | 13 Jun 2024 |
Netscientific PLC Directors
| Appointed | Name | Position |
|---|---|---|
| 2020-12-02 | Sir Richard Brook Sykes | Non-Executive Director,Chairman |
| 2019-12-13 | Mr. Barry Woodrow Wilson | Non-Executive Director |
| 2023-07-07 | Mr. Stephen Daniel Crowe | Company Secretary |
| 2020-05-01 | Mr. Ian David Postlethwaite | Executive Director,Chief Executive Officer, Chief Financial Officer and Company Secretary |
| 2024-06-13 | Dr. Charles Alexander Evan Spicer | Non-Executive Director,Chairman |
| 2024-06-13 | Dr. Jonathan Mark Robinson | Non-Executive Director,Senior Independent Director |
| 2015-05-18 | Mr. Farad Azima | Executive Director,Chief Executive Officer |
| 2015-12-31 | Dr. Michael Thomas Boyce-Jacino | Executive Director,Chief Operating Officer |
| 2017-05-26 | Mr. Peter Young Thoms | Executive Director,Chief Financial Officer |
| 2016-05-23 | Mr. Nicholas Charles Heckford | Executive Director,Commercial and Legal Director |
| 2015-12-31 | Mr. David Anthony Gough | Executive Director,Chief Technology Officer |
| 2019-05-28 | Dr. Francois Regis Martelet | Executive Director,Chief Executive Officer |
| 2023-05-31 | Professor Stephen Kevin Smith | Non-Executive Director |
| 2024-06-13 | Dr. Ilian Petkov Iliev | Executive Director,Chief Executive Officer |
| 2024-06-13 | Mr. John Eric Clarkson | Non-Executive Director,Chairman |
| 2020-12-02 | Stephen Daniel Crowe | Executive Director,Chief Financial Officer and Company Secretary |
| 2022-12-27 | Mr. Clive Bertram Sparrow | Non-Executive Director |
| 2024-06-14 | Mr. Edward Benjamin Peter Hooper | Executive Director,General Counsel |
| 2016-05-23 | Lady Barbara Thomas Judge CBE | Non-Executive Director |
Netscientific PLC Contact Details
| Company Name | NetScientific PLC |
|---|---|
| Address | Bell Lane, Anglo House, Bell Lane Office Village, Amersham, HP6 6FA |
| Telephone | +44 2035141800 |
| Website | https://www.netscientific.net |
Netscientific PLC Advisors
| Stockbroker | Stifel Nicolaus Europe Ltd |
|---|---|
| Phone | +44 2077107600 |
| Fax | +44 2077107609 |
| Nominated Adviser | Stifel Nicolaus Europe Ltd |
|---|---|
| Phone | +44 2077107600 |
| Fax | +44 2077107609 |
| Financial PR Adviser | Consilium Strategic Communications |
|---|---|
| Phone | +44 2037095700 |
| Solicitor | DLA Piper LLP |
|---|---|
| Phone | +44 8700111111 |
| Fax | +44 2077966666 |
| Auditor | BDO LLP |
|---|---|
| Phone | +44 2380881700 |
| Fax | +44 2380881701 |
| Registrar | Capita Asset Services |
|---|---|
| Phone | +44 1484600904 |
| Bank | HSBC Bank PLC |
|---|
Receive our
daily news email
Subscribe to the latest investing news by entering your email address below
You can opt out at any time.
For five days a week you will get
- The latest company news
- Insight into investment trends
- Round-up of director's buys and sells
- Articles from Shares magazine
Plus more useful investment content and occasional promotional offers.
Market Overview
UK 350 Risers and Fallers
Risers
| Company | Price | % Chg |
|---|---|---|
| Watches Of Switzerland Group PLC | 473.40 | 11.13 |
| Burberry Group PLC | 663.80 | 8.71 |
| Hochschild Mining PLC | 198.80 | 6.31 |
| Fidelity China Special Situations PLC | 199.20 | 6.18 |
| Anglo American PLC | 2,439.50 | 6.16 |
| Prudential PLC | 681.60 | 6.14 |
Fallers
| Company | Price | % Chg |
|---|---|---|
| Shell PLC | 2,415.00 | -4.62 |
| Petershill Partners PLC | 213.00 | -4.48 |
| BP PLC | 383.85 | -4.10 |
| Raspberry Pi Holdings PLC | 375.20 | -3.70 |
| Future PLC | 993.50 | -3.17 |
| Aston Martin Lagonda Global Holdings PLC | 151.40 | -3.14 |
Risers/fallers data from previous trading day. Today's data available from 8:15am.